Peter J. Worland

5.8k total citations
46 papers, 4.7k citations indexed

About

Peter J. Worland is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Peter J. Worland has authored 46 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 20 papers in Oncology and 10 papers in Cell Biology. Recurrent topics in Peter J. Worland's work include Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Peter J. Worland is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). Peter J. Worland collaborates with scholars based in United States, Australia and Canada. Peter J. Worland's co-authors include Edward A. Sausville, Gurmeet Kaur, Leonardo Brizuela, Bradley A. Carlson, Qizhi Wang, Michael D. Losiewicz, Ursula Schulze‐Gahmen, Walter Filgueira de Azevedo, S H Kim and Songqing Fan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Peter J. Worland

46 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Worland United States 28 2.9k 2.4k 813 622 444 46 4.7k
W. Robert Bishop United States 35 4.4k 1.5× 1.9k 0.8× 685 0.8× 302 0.5× 527 1.2× 71 5.9k
Yoon S. Cho‐Chung United States 43 4.1k 1.4× 1.9k 0.8× 340 0.4× 464 0.7× 620 1.4× 159 6.4k
Vivek M. Rangnekar United States 46 4.1k 1.4× 1.3k 0.5× 879 1.1× 534 0.9× 960 2.2× 119 6.0k
Markus Wartmann Switzerland 39 3.8k 1.3× 2.1k 0.9× 948 1.2× 680 1.1× 650 1.5× 89 6.9k
Román Herrera United States 26 6.7k 2.3× 1.8k 0.7× 812 1.0× 294 0.5× 738 1.7× 42 8.6k
Cristiano Ferlini Italy 41 3.0k 1.0× 1.7k 0.7× 997 1.2× 508 0.8× 1.0k 2.3× 136 5.3k
Ching-Shih Chen United States 46 3.3k 1.1× 920 0.4× 755 0.9× 321 0.5× 652 1.5× 83 5.3k
Michiaki Kohno Japan 35 3.1k 1.1× 846 0.3× 523 0.6× 285 0.5× 531 1.2× 92 4.5k
Solly Weiler United States 18 5.6k 2.0× 971 0.4× 747 0.9× 228 0.4× 582 1.3× 37 6.9k
Kiyotsugu Yoshida Japan 40 4.0k 1.4× 1.5k 0.6× 439 0.5× 276 0.4× 859 1.9× 108 5.4k

Countries citing papers authored by Peter J. Worland

Since Specialization
Citations

This map shows the geographic impact of Peter J. Worland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Worland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Worland more than expected).

Fields of papers citing papers by Peter J. Worland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Worland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Worland. The network helps show where Peter J. Worland may publish in the future.

Co-authorship network of co-authors of Peter J. Worland

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Worland. A scholar is included among the top collaborators of Peter J. Worland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Worland. Peter J. Worland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henry, Michael D., Matthew D. Silva, Shenghua Wen, et al.. (2005). Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients. The Prostate. 65(4). 347–354. 21 indexed citations
2.
Henry, Michael D., Shenghua Wen, Matthew D. Silva, et al.. (2004). A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer. Cancer Research. 64(21). 7995–8001. 124 indexed citations
3.
Gray, Karen, David P. Schenkein, Barry R. Greene, et al.. (2003). Antibody-based therapeutics in oncology. Expert Review of Anticancer Therapy. 3(1). 107–121. 37 indexed citations
4.
Sandhu, Charanjit, Jeffrey Donovan, Nandita Bhattacharya, et al.. (2000). Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Oncogene. 19(47). 5314–5323. 45 indexed citations
5.
Carlson, Brett L., Tyler Lahusen, Shradha Singh, et al.. (1999). Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.. PubMed. 59(18). 4634–41. 215 indexed citations
6.
Cady, Blake, Molly Wanner, Peter J. Worland, et al.. (1997). The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.. PubMed. 57(7). 1259–63. 298 indexed citations
7.
Reifsteck, Carol, et al.. (1997). Fanconi anemia group A and D cell lines respond normally to inhibitors of cell cycle regulation. Somatic Cell and Molecular Genetics. 23(6). 371–377. 9 indexed citations
8.
Carlson, Bradley A., et al.. (1996). Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.. PubMed. 56(13). 2973–8. 454 indexed citations
9.
Wang, Qizhi, Songqing Fan, Alan Eastman, et al.. (1996). UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53. JNCI Journal of the National Cancer Institute. 88(14). 956–965. 369 indexed citations
10.
Kroog, Glenn S., Eduardo Sainz, Peter J. Worland, et al.. (1995). The Gastrin-releasing Peptide Receptor Is Rapidly Phosphorylated by a Kinase Other Than Protein Kinase C After Exposure to Agonist. Journal of Biological Chemistry. 270(14). 8217–8224. 41 indexed citations
11.
Wang, Qizhi, et al.. (1995). Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.. PubMed. 6(8). 927–36. 117 indexed citations
12.
Losiewicz, Michael D., et al.. (1994). Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275. Biochemical and Biophysical Research Communications. 201(2). 589–595. 285 indexed citations
13.
Worland, Peter J., et al.. (1993). Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Biochemical Pharmacology. 46(10). 1831–1840. 122 indexed citations
14.
Kaur, Gurmeet, M Stetler-Stevenson, Peter J. Worland, et al.. (1992). Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275. JNCI Journal of the National Cancer Institute. 84(22). 1736–1740. 301 indexed citations
15.
Workman, Barbara, E. L. Conway, Peter J. Worland, et al.. (1992). Single-Dose and Steady-State Pharmacokinetics and Pharmacodynamics of Perindopril in Hypertensive Subjects. Journal of Cardiovascular Pharmacology. 20(3). 505–505. 17 indexed citations
16.
Hatfield, Dolph L., David W. Smith, Byeong J. Lee, Peter J. Worland, & Stephen Oroszlan. (1990). Structure and Function of Suppressor tRNAs in Higher Eukaryote. Critical Reviews in Biochemistry and Molecular Biology. 25(2). 71–96. 47 indexed citations
17.
Hampton, Lori L., Peter J. Worland, Bin Yu, Snorri S. Thorgeirsson, & Anthony C. Huggett. (1990). Expression of growth-related genes during tumor progression in v-raf-transformed rat liver epithelial cells.. PubMed. 50(23). 7460–7. 20 indexed citations
18.
Verberne, Anthony J.M., Stephen J. Lewis, Peter J. Worland, et al.. (1987). Medial prefrontal cortical lesions modulate baroreflex sensitivity in the rat. Brain Research. 426(2). 243–249. 93 indexed citations
19.
Worland, Peter J., Olaf H. Drummer, & Bevyn Jarrott. (1984). Gastric and Intestinal Absorption of Captopril in Acutely and Chronically Treated Rats: Comparison with Salicylic Acid. Journal of Pharmaceutical Sciences. 73(12). 1755–1758. 18 indexed citations
20.
Moulds, Robert F.W. & Peter J. Worland. (1980). Potentiation of Human Vascular Smooth Muscle Contraction by Angiotensin. Journal of Cardiovascular Pharmacology. 2(4). 377–386. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Robert Bishop Breakdown of academic impact, for papers by Yoon S. Cho‐Chung Breakdown of academic impact, for papers by Vivek M. Rangnekar Breakdown of academic impact, for papers by Markus Wartmann Breakdown of academic impact, for papers by Román Herrera Breakdown of academic impact, for papers by Cristiano Ferlini Breakdown of academic impact, for papers by Ching-Shih Chen Breakdown of academic impact, for papers by Michiaki Kohno Breakdown of academic impact, for papers by Solly Weiler Breakdown of academic impact, for papers by Kiyotsugu Yoshida
Rankless by CCL
2026